(Q30376925)

21 June 2017

title

Evaluation of conserved and variable influenza antigens for immunization against different isolates of H5N1 viruses. (English)

1 reference

21 June 2017

0 references

7

Darwyn Kobasa

1 reference

21 June 2017

8

Gary P Kobinger

1 reference

21 June 2017

2

Kaylie Tran

1 reference

21 June 2017

6

Xiaojian Yao

1 reference

21 June 2017

5

Zhujun Ao

1 reference

21 June 2017

Ami Patel

1

1 reference

21 June 2017

Michael Gray

series ordinal

3

1 reference

21 June 2017

Yan Li

series ordinal

4

1 reference

21 June 2017

language of work or name

English

0 references

publication date

1 April 2009

1 reference

21 June 2017

number of pages

7

1 reference

inferred from page(s)

published in

Vaccine

1 reference

21 June 2017

volume

27

1 reference

21 June 2017

issue

23

1 reference

21 June 2017

page(s)

3083-3089

1 reference

Establishment of multiple sublineages of H5N1 influenza virus in Asia: Implications for pandemic control

21 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.03.023

Enhanced protective efficacy of H5 subtype avian influenza DNA vaccine with codon optimized HA gene in a pCAGGS plasmid vector

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.03.023

Predicting the global spread of H5N1 avian influenza

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.03.023

Characterization of the 1918 influenza virus polymerase genes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.03.023

Characterization of the reconstructed 1918 Spanish influenza pandemic virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.03.023

Updating the Accounts: Global Mortality of the 1918-1920 "Spanish" Influenza Pandemic

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.03.023

Making better influenza virus vaccines?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.03.023

Safety of cold-adapted live attenuated influenza vaccine in a large cohort of children and adolescents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.03.023

Safety and immunogenicity of an inactivated subvirion influenza A (H5N1) vaccine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.03.023

From plasmids to protection: a review of DNA vaccines against infectious diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.03.023

Immunogenicity of novel consensus-based DNA vaccines against avian influenza.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.03.023

Codon optimization of the tat antigen of human immunodeficiency virus type 1 generates strong immune responses in mice following genetic immunization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.03.023

Codon usage patterns in Escherichia coli, Bacillus subtilis, Saccharomyces cerevisiae, Schizosaccharomyces pombe, Drosophila melanogaster and Homo sapiens; a review of the considerable within-species diversity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.03.023

Strategies for inducing protection against avian influenza A virus subtypes with DNA vaccines.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.03.023

Protection against multiple influenza A subtypes by vaccination with highly conserved nucleoprotein.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.03.023

Characterization of a trypsin-dependent avian influenza H5N1-pseudotyped HIV vector system for high throughput screening of inhibitory molecules

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.03.023

Chimpanzee adenovirus vaccine protects against Zaire Ebola virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.03.023

Mucosal delivery of adenovirus-based vaccine protects against Ebola virus infection in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.03.023

Multivalent HA DNA vaccination protects against highly pathogenic H5N1 avian influenza infection in chickens and mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.03.023

Strategies for developing vaccines against H5N1 influenza A viruses.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.03.023

H5N1 viruses and vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.03.023

Cross-protectiveness and immunogenicity of influenza A/Duck/Singapore/3/97(H5) vaccines against infection with A/Vietnam/1203/04(H5N1) virus in ferrets

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.03.023

Influenza virus-specific cytotoxic T lymphocytes: a correlate of protection and a basis for vaccine development.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.03.023

Protection of mice and poultry from lethal H5N1 avian influenza virus through adenovirus-based immunization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.03.023

DNA vaccine expressing conserved influenza virus proteins protective against H5N1 challenge infection in mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.03.023

Heterosubtypic protection against pathogenic human and avian influenza viruses via in vivo electroporation of synthetic consensus DNA antigens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.03.023

A broadly protective vaccine against globally dispersed clade 1 and clade 2 H5N1 influenza viruses.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.03.023

Detection of antibody to avian influenza A (H5N1) virus in human serum by using a combination of serologic assays.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.03.023

7 January 2021

inferred from DOI database lookup

Protective CD4+ and CD8+ T cells against influenza virus induced by vaccination with nucleoprotein DNA

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.03.023

7 January 2021

inferred from DOI database lookup

Protective cellular immunity: cytotoxic T-lymphocyte responses against dominant and recessive epitopes of influenza virus nucleoprotein induced by DNA immunization

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.03.023

7 January 2021

inferred from DOI database lookup

Identifiers

DOI

10.1016/J.VACCINE.2009.03.023

1 reference

21 June 2017

1 reference